[go: up one dir, main page]

MX163553B - Metodo para preparar una forma de liberacion sustentada solida de una composicion funcionalmente activa - Google Patents

Metodo para preparar una forma de liberacion sustentada solida de una composicion funcionalmente activa

Info

Publication number
MX163553B
MX163553B MX13891A MX1389188A MX163553B MX 163553 B MX163553 B MX 163553B MX 13891 A MX13891 A MX 13891A MX 1389188 A MX1389188 A MX 1389188A MX 163553 B MX163553 B MX 163553B
Authority
MX
Mexico
Prior art keywords
functionally active
preparing
active composition
sustainable release
granule
Prior art date
Application number
MX13891A
Other languages
English (en)
Inventor
James William Mcginity
Kuei-Tu Chang
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of MX163553B publication Critical patent/MX163553B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX13891A 1987-11-24 1988-11-22 Metodo para preparar una forma de liberacion sustentada solida de una composicion funcionalmente activa MX163553B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12470587A 1987-11-24 1987-11-24

Publications (1)

Publication Number Publication Date
MX163553B true MX163553B (es) 1992-05-29

Family

ID=22416371

Family Applications (1)

Application Number Title Priority Date Filing Date
MX13891A MX163553B (es) 1987-11-24 1988-11-22 Metodo para preparar una forma de liberacion sustentada solida de una composicion funcionalmente activa

Country Status (9)

Country Link
EP (1) EP0387300B1 (es)
JP (1) JPH02503315A (es)
KR (1) KR890701138A (es)
AT (1) ATE94410T1 (es)
AU (1) AU2793989A (es)
CA (1) CA1334379C (es)
DE (1) DE3884214T2 (es)
MX (1) MX163553B (es)
WO (1) WO1989004673A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI900469A0 (fi) * 1989-01-31 1990-01-30 Int Pharma Agentur Aktivaemnen avgivande system med kontrollerad erosion och foerfarande foer dess framstaellning.
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
EP0429832B1 (de) * 1989-11-30 1994-06-22 PCD-Polymere Gesellschaft m.b.H. Nicht wirkstoffretardierender Pressling, Verfahren zu dessen Herstellung und Verwendung von Polyhydroxybuttersäure zur Herstellung eines solchen Presslings
DE4000155A1 (de) * 1990-01-04 1991-07-11 Chemie Linz Deutschland Nicht wirkstoffretardierender pressling, verfahren zu dessen herstellung und verwendung von polyhydroxybuttersaeure zur herstellung eines solchen presslings
AT397345B (de) * 1990-04-04 1994-03-25 Chemiefaser Lenzing Ag Pharmazeutisches präparat mit verzögerter wirkstofffreisetzung auf basis von hemicellulosen
US5429825A (en) * 1992-06-26 1995-07-04 Mcneil-Ppc, Inc. Rotomelt granulation
JP3277342B2 (ja) * 1992-09-02 2002-04-22 武田薬品工業株式会社 徐放性マイクロカプセルの製造法
TW333456B (en) 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
US5858411A (en) * 1994-12-19 1999-01-12 Daiichi Pharmaceutical Co., Ltd. Sustained-release granular preparations and production process thereof
US5656294A (en) * 1995-06-07 1997-08-12 Cibus Pharmaceutical, Inc. Colonic delivery of drugs
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
DE69615763T2 (de) * 1995-07-13 2002-08-08 Mitsubishi Gas Chemical Co., Inc. Polymermischungen aliphatischer Polyester auf Basis von Polylactiden, Verfahren zu deren Herstellung und Verfahren zum Formen diese Mischungen
TW448055B (en) * 1995-09-04 2001-08-01 Takeda Chemical Industries Ltd Method of production of sustained-release preparation
CA2192773C (en) 1995-12-15 2008-09-23 Hiroaki Okada Production of sustained-release preparation for injection
US6419961B1 (en) 1996-08-29 2002-07-16 Takeda Chemical Industries, Ltd. Sustained release microcapsules of a bioactive substance and a biodegradable polymer
CA2317039C (en) 1998-01-21 2009-09-29 Takeda Chemical Industries, Ltd. Lyophilization method for sustained-release preparations
AU2484399A (en) * 1998-01-30 1999-08-16 Scios Inc. Controlled release delivery of peptide or protein
CN100356907C (zh) * 2001-06-08 2007-12-26 恩德制药公司 利用丙烯酸酯聚合物的控释剂型和其制备方法
JP5209876B2 (ja) * 2004-12-28 2013-06-12 エーザイ・アール・アンド・ディー・マネジメント株式会社 速崩壊性錠剤及びその製造方法
US10328015B2 (en) 2014-01-23 2019-06-25 Amkiri Ltd. Fragrance releasing compositions
ES2899888T3 (es) * 2014-01-23 2022-03-15 Maori S C Ltd Composiciones corporales perfumadas

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE27107E (en) * 1968-05-01 1971-03-30 Drug composition
JPS5138412A (en) * 1974-09-24 1976-03-31 Nippon Kayaku Kk Kokoseizai no seiho
DE2930321A1 (de) * 1978-09-25 1980-04-10 Jenapharm Veb Verfahren zur herstellung eines neuen pharmazeutischen hilfsstoffes und daraus hergestellte feste arzneiformen
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4308251A (en) * 1980-01-11 1981-12-29 Boots Pharmaceuticals, Inc. Controlled release formulations of orally-active medicaments
IT1168014B (it) * 1981-08-05 1987-05-20 Erba Farmitalia Forme farmaceutiche a cessione protratta
DE3435325A1 (de) * 1983-04-09 1986-04-17 Nikken Chemicals Co., Ltd., Tokio/Tokyo Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung
HU190619B (en) * 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
US4725342A (en) * 1986-11-10 1988-02-16 Yale University Photochemical dimerization and functionalization of alkanes, ethers, primary alcohols and silanes

Also Published As

Publication number Publication date
JPH02503315A (ja) 1990-10-11
CA1334379C (en) 1995-02-14
EP0387300B1 (en) 1993-09-15
ATE94410T1 (de) 1993-10-15
DE3884214D1 (de) 1993-10-21
AU2793989A (en) 1989-06-14
DE3884214T2 (de) 1994-01-13
EP0387300A1 (en) 1990-09-19
KR890701138A (ko) 1989-12-19
WO1989004673A1 (en) 1989-06-01

Similar Documents

Publication Publication Date Title
MX163553B (es) Metodo para preparar una forma de liberacion sustentada solida de una composicion funcionalmente activa
NO841518L (no) Delbare tabletter med forsinket frigjoering av virkestoff, og fremgangsmaate for fremstilling derav
ES488168A0 (es) Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada.
AR008002A1 (es) Formulaciones de unidades múltiples de tramadol y procedimiento para prepararlas.
HU910274D0 (en) Process for the production of medical preparations containing tulobuterol usable for transdermal feeding
CY1105319T1 (el) Ταχεως αποσαθρουμενη απο του στοματος συνταγοποιηση του valdecoxib
AR002275A1 (es) Forma de dosificacion farmaceutica oral, procedimiento para la manufactura de una forma de dosificacion fija, y uso de dicha forma de dosificacionfarmaceutica oral.
ATE86479T1 (de) Pharmazeutische matrix mit verzoegerter freisetzung und verfahren.
NZ234587A (en) A chewable pharmaceutical tablet of compressed coated granules
ES541513A0 (es) Procedimiento para la obtencion de comprimidos de sustancia activa farmaceutica, de rapida desintegracion
PT833618E (pt) Forma farmaceutica solida para utilizacao oral
HU908404D0 (en) Process for the production of preparations with 1-carnitine content
UA18251A (uk) Спосіб одержаhhя таблеток з безперервhим виділеhhям лікарського засобу
ATE81450T1 (de) Retardierte arzneiform und verfahren zu ihrer herstellung.
RU93036959A (ru) Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства
ES2034035T3 (es) Procedimiento de preparacion de una forma farmaceutica para la administracion y/o dosificacion de medicamentos.
ES2010466A6 (es) Formas de administracion solidas, de rapida desintegracion.
HU9301672D0 (en) Method for manufacturing solid dosing forms of medicaments with controlled releasing of active agents
AR005353A1 (es) Formulacion de hormona para crecimiento animal de liberacion sostenida, y un procedimiento para la preparacion de la misma
KR900004326A (ko) 디히드로에르고톡신 및 그의 산 부가염의 분산성 정제
SK4895A3 (en) More easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent
ES2052816T3 (es) Una composicion para revestir granulos de farmacos.
SI8710406B (sl) Tablete s podaljšanim delovanjem na osnovi hidroksipropilmetilceluloze z veliko molsko maso in postopek za njihovo pripravo
ES2088550T3 (es) Recubrimientos que ocultan el sabor para preparar comprimidos farmaceuticos masticables.
NO20054417L (no) Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter